Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 23, 2012

Litwin v. Human Genome Sciences Inc. et al

Track this case

Case Number:

1:12-cv-00979

Court:

Delaware

Nature of Suit:

Stockholders Suits

Multi Party Litigation:

Class Action

Judge:

Sue L. Robinson

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 25, 2012

    Human Genome Shareholders Say GSK's $3B Offer Too Low

    Just two weeks after announcing its drawn-out $3 billion takeover of U.S. biotech company Human Genome Sciences Inc., British drugmaker GlaxoSmithKline PLC was hit Monday with a putative class action from Human Genome shareholders who say the price tag is too low.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login